» Articles » PMID: 20176693

European Guidelines for Quality Assurance in Cervical Cancer Screening. Second Edition--summary Document

Overview
Journal Ann Oncol
Publisher Elsevier
Specialty Oncology
Date 2010 Feb 24
PMID 20176693
Citations 177
Authors
Affiliations
Soon will be listed here.
Abstract

European Guidelines for Quality Assurance in Cervical Cancer Screening have been initiated in the Europe Against Cancer Programme. The first edition established the principles of organised population-based screening and stimulated numerous pilot projects. The second multidisciplinary edition was published in 2008 and comprises approximately 250 pages divided into seven chapters prepared by 48 authors and contributors. Considerable attention has been devoted to organised, population-based programme policies which minimise adverse effects and maximise benefits of screening. It is hoped that this expanded guidelines edition will have a greater impact on countries in which screening programmes are still lacking and in which opportunistic screening has been preferred in the past. Other methodological aspects such as future prospects of human papillomavirus testing and vaccination in cervical cancer control have also been examined in the second edition; recommendations for integration of the latter technologies into European guidelines are currently under development in a related project supported by the European Union Health Programme. An overview of the fundamental points and principles that should support any quality-assured screening programme and key performance indicators are presented here in a summary document of the second guidelines edition in order to make these principles and standards known to a wider scientific community.

Citing Articles

Cervical cancer screening by cotesting method for Vietnamese women 25-55 years old: a cost-effectiveness analysis.

Bui H, Pham V, Vu T BMJ Open. 2025; 15(1):e082145.

PMID: 39843369 PMC: 11758702. DOI: 10.1136/bmjopen-2023-082145.


Extended HPV genotyping by the BD Onclarity assay: concordance with screening HPV-DNA assays, triage biomarkers, and histopathology in women from the NTCC2 study.

De Marco L, Bisanzi S, Ronco G, Mancuso P, Carozzi F, Allia E Microbiol Spectr. 2024; 13(1):e0089724.

PMID: 39576120 PMC: 11723576. DOI: 10.1128/spectrum.00897-24.


Use of Cervical Cancer Screening among Patients of Primary Healthcare Services: Northeast Portugal.

Teixeira C, Antao C, Anes E, Gomes M, Versos A, Tome C Port J Public Health. 2024; 40(2):61-68.

PMID: 39469083 PMC: 11320112. DOI: 10.1159/000522666.


Effects of screening coverage and screening quality assurance on cervical cancer mortality: Implication for integrated framework to monitor global implementation of cervical cancer screening programmes.

Wang M, Chen H, Wong M, Huang J, Jin Y, Zheng Z J Glob Health. 2024; 14:04189.

PMID: 39450607 PMC: 11503509. DOI: 10.7189/jogh.14.04189.


Population-based age- and type-specific prevalence of human papillomavirus among non-vaccinated women aged 30 years and above in Germany.

Liang L, Tanaka L, Radde K, Bussas U, Ikenberg H, Heideman D BMC Infect Dis. 2024; 24(1):1008.

PMID: 39300354 PMC: 11414300. DOI: 10.1186/s12879-024-09827-7.


References
1.
Wiener H, Klinkhamer P, Schenck U, Arbyn M, Bulten J, Bergeron C . European guidelines for quality assurance in cervical cancer screening: recommendations for cytology laboratories. Cytopathology. 2007; 18(2):67-78. DOI: 10.1111/j.1365-2303.2007.00451.x. View

2.
Arbyn M, Raifu A, Autier P, Ferlay J . Burden of cervical cancer in Europe: estimates for 2004. Ann Oncol. 2007; 18(10):1708-15. DOI: 10.1093/annonc/mdm079. View

3.
Ronco G, Cuzick J, Pierotti P, Cariaggi M, Dalla Palma P, Naldoni C . Accuracy of liquid based versus conventional cytology: overall results of new technologies for cervical cancer screening: randomised controlled trial. BMJ. 2007; 335(7609):28. PMC: 1910655. DOI: 10.1136/bmj.39196.740995.BE. View

4.
Arbyn M, Dillner J . Review of current knowledge on HPV vaccination: an appendix to the European Guidelines for Quality Assurance in Cervical Cancer Screening. J Clin Virol. 2007; 38(3):189-97. DOI: 10.1016/j.jcv.2006.12.009. View

5.
Arbyn M, Herbert A, Schenck U, Nieminen P, Jordan J, Mcgoogan E . European guidelines for quality assurance in cervical cancer screening: recommendations for collecting samples for conventional and liquid-based cytology. Cytopathology. 2007; 18(3):133-9. DOI: 10.1111/j.1365-2303.2007.00464.x. View